Toll-Like Receptor 2-Dependent Protection against Pneumococcal Carriage by Immunization with Lipidated Pneumococcal Proteins

被引:31
|
作者
Moffitt, Kristin [1 ]
Skoberne, Mojca [2 ]
Howard, Angela [1 ]
Gavrilescu, Cristina [2 ]
Gierahn, Todd [2 ]
Munzer, Scott [2 ]
Dixit, Bharat [2 ]
Giannasca, Paul [2 ]
Flechtner, Jessica Baker [2 ]
Malley, Richard [1 ]
机构
[1] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA 02115 USA
[2] Genocea Biosci Inc, Cambridge, MA USA
关键词
ACUTE OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE; DENDRITIC CELLS; TH17; CELLS; COLONIZATION; CONJUGATE; IMMUNITY; DISEASE; INNATE; RECOGNITION;
D O I
10.1128/IAI.01632-13
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infections with Streptococcus pneumoniae cause substantial morbidity and mortality, particularly in children in developing nations. Polysaccharide-conjugate vaccines provide protection against both invasive disease and colonization, but their use in developing countries is limited by restricted serotype coverage and expense of manufacture. Using proteomic screens, we recently identified several antigens that protected mice from pneumococcal colonization in a CD4+ T cell-and interleukin-17A (IL-17A)dependent manner. Since several of these proteins are lipidated, we hypothesized that their immunogenicity and impact on colonization are in part due to activation of Toll-like receptor 2 (TLR2), a receptor for lipoproteins. Here we show that lipidated versions of the antigens elicited significantly higher activation of both human embryonic kidney cells engineered to express TLR2 (HEK-TLR2) and wild-type (WT) murine macrophages than nonlipidated mutant antigens. Lipoprotein-stimulated secretion of proinflammatory cytokines was similar to 10x to similar to 100x lower in murine TLR2-deficient macrophages than in WT macrophages. Subcutaneous immunization of C57BL/6 mice with protein subunit vaccines containing one or two of these lipoproteins or protein fusion constructs bearing N-terminal lipid adducts elicited a robust IL-17A response and a significant reduction in colonization compared with immunization with alum alone. In contrast, immunization of Tlr2(-/)-mice elicited no detectable IL-17A response and no protection against pneumococcal colonization. These experiments suggest that the lipid moieties enhance the immunogenicity and protective efficacy of pneumococcal T(H)17 antigens through activation of TLR2. Thus, triggering TLR2 with an antigen-specific protein subunit formulation is a possible strategy for the development of a serotype-independent pneumococcal vaccine that would reduce pneumococcal carriage.
引用
收藏
页码:2079 / 2086
页数:8
相关论文
共 50 条
  • [1] Toll-Like Receptor 4, But Not Toll-Like Receptor 2, is Necessary for Protection Against Corneal Damage During Pneumococcal Keratitis
    Tullos, N. A.
    Norcross, E.
    Taylor, S.
    Moore, Q. C., III
    Sanders, M. E.
    Marquart, M. E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [2] TH17-Mediated Protection against Pneumococcal Carriage by a Whole-Cell Vaccine Is Dependent on Toll-Like Receptor 2 and Surface Lipoproteins
    Moffitt, K.
    Howard, A.
    Martin, S.
    Cheung, E.
    Herd, M.
    Basset, A.
    Malley, R.
    CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (08) : 909 - 916
  • [3] Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease
    Moens, Leen
    Verhaegen, Jan
    Pierik, Marie
    Vermeire, Severine
    De Boeck, Kris
    Peetermans, Willy E.
    Bossuyt, Xavier
    MICROBES AND INFECTION, 2007, 9 (01) : 15 - 20
  • [4] The apoptotic response to pneumolysin is toll-like receptor 4 dependent and protects against pneumococcal disease
    Srivastava, A
    Henneke, P
    Visintin, A
    Morse, SC
    Martin, V
    Watkins, C
    Paton, JC
    Wessels, MR
    Golenbock, DT
    Malley, R
    INFECTION AND IMMUNITY, 2005, 73 (10) : 6479 - 6487
  • [5] Toll-like receptor signaling in pneumococcal disease.
    Turvey, SE
    Aderem, A
    Bettinger, J
    Currie, A
    Davidson, D
    Hawn, T
    Hirschfeld, A
    Junker, A
    Scheifele, D
    Speert, D
    CLINICAL IMMUNOLOGY, 2005, 116 (03) : 302 - 302
  • [6] Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins
    Cao, Ju
    Zhang, Xiaojiao
    Gong, Yi
    Zhang, Yuhong
    Cui, Yali
    Lai, Xiaofei
    Yin, Yibing
    Li, Meijuan
    Li, Dairong
    Zhang, Liping
    VACCINE, 2013, 31 (35) : 3564 - 3571
  • [7] The effect of toll-like receptor (TLR)-2 agonist PamCys in pneumococcal meningitis
    Sellner, J.
    Gianinazzi, C.
    Landmann, R.
    Leib, S. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 33 - 33
  • [8] Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection
    Albiger, Barbara
    Dahlberg, Sofia
    Sandgren, Andreas
    Wartha, Florian
    Beiter, Katharina
    Katsuragi, Hiroaki
    Akira, Shizuo
    Normark, Staffan
    Henriques-Normark, Birgitta
    CELLULAR MICROBIOLOGY, 2007, 9 (03) : 633 - 644
  • [9] Association of toll-like receptor 10 polymorphisms with pediatric pneumococcal meningitis
    Xiang, Qiaoyan
    Zhu, Liang
    Zheng, Kai
    Ding, Yiwei
    Chen, Ning
    Liu, Gang
    He, Qiushui
    APMIS, 2020, 128 (04) : 335 - 342
  • [10] Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis
    Koedel, U
    Angele, B
    Rupprecht, T
    Wagner, H
    Roggenkamp, A
    Pfister, HW
    Kirschning, CJ
    JOURNAL OF IMMUNOLOGY, 2003, 170 (01): : 438 - 444